David Taber
Impact in
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- Cancer-related Molecular Pathways
- Colorectal Cancer Treatments and Studies
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 7
- Colorectal Cancer Treatments and Studies 4
- Cancer Treatment and Pharmacology 2
-
- Lung Cancer Treatments and Mutations 3
- Renal cell carcinoma treatment 2
- Co-authors
- Walter M. Stadler (8 shared papers)Everett E. Vokes (13 shared papers)Nicholas J. Vogelzang (5 shared papers)Hedy L. Kindler (7 shared papers)Theodore Karrison (3 shared papers)Mark Kozloff (4 shared papers)D. A. Singh (3 shared papers)Sreenivasa Nattam (2 shared papers)
- Journals
- Journal of Clinical Oncology (10 papers)Journal of the American Oil Chemists Society (4 papers)Investigational New Drugs (3 papers)Journal of the American Chemical Society (2 papers)Journal of Medicinal Chemistry (1 paper)
- Partner nations
- United States
In The Last Decade
David Taber
28 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 84
- Oncology 572
- Cancer Research 229
- Pulmonary and Respiratory Medicine 413
- Otorhinolaryngology 39
- Molecular Biology 401
Countries citing papers authored by David Taber
This map shows the geographic impact of David Taber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Taber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Taber more than expected).
Fields of papers citing papers by David Taber
This network shows the impact of papers produced by David Taber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Taber. The network helps show where David Taber may publish in the future.
Co-authors
The 25 scholars most cited alongside David Taber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 376 | |
| 2 | 2000 | 178 | |
| 3 | 2012 | 149 | |
| 4 | 2000 | 127 | |
| 5 | 2003 | 119 | |
| 6 | 2009 | 68 | |
| 7 | 2011 | 43 | |
| 8 | 2008 | 20 | |
| 9 | 2005 | 15 | |
| 10 | 1954 | 14 | |
| 11 | 2008 | 14 | |
| 12 | 1956 | 10 | |
| 13 | 2006 | 10 | |
| 14 | 2012 | 10 | |
| 15 | 1972 | 7 | |
| 16 | 1971 | 6 | |
| 17 | 2005 | 6 | |
| 18 | 2009 | 5 | |
| 19 | 1967 | 5 | |
| 20 | Phase II and pharmacodynamic studies of pyrazine diazohydroxide (NSC 361456) in patients with advanced renal and colorectal cancer. | 1998 | 5 |
About David Taber
David Taber is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Organic Chemistry, Molecular Biology and Surgery, having authored 28 papers that have together received 1.2k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (4 papers), Antimicrobial agents and applications (3 papers), Lung Cancer Treatments and Mutations (3 papers), Renal cell carcinoma treatment (2 papers), Cancer Treatment and Pharmacology (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Cancer therapeutics and mechanisms (2 papers) and Chemical Reactions and Isotopes (2 papers). The work is most often cited by research in Oncology (572 citations), Cancer Research (229 citations), Pulmonary and Respiratory Medicine (413 citations), Otorhinolaryngology (39 citations) and Molecular Biology (401 citations). David Taber has collaborated with scholars based in United States. Frequent co-authors include Walter M. Stadler, Everett E. Vokes, Nicholas J. Vogelzang, Hedy L. Kindler, Theodore Karrison, Mark Kozloff, D. A. Singh, Sreenivasa Nattam, Gershon Y. Locker and Gregory Friberg. Their work appears in journals such as Journal of Clinical Oncology, Journal of the American Oil Chemists Society, Investigational New Drugs, Journal of the American Chemical Society and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.